These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35231546)

  • 1. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
    Lim GF; Perez OA; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
    Sohn GK; Keniston K; Kannan S; Hinds B; Jiang SIB
    J Drugs Dermatol; 2021 Mar; 20(3):283-288. PubMed ID: 33683071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane.
    Orengo IF; Salasche SJ; Fewkes J; Khan J; Thornby J; Rubin F
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):395-7. PubMed ID: 9308552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins.
    Santos-Arroyo A; Carrasquillo OY; Cardona R; Sánchez JL; Valentín-Nogueras S
    P R Health Sci J; 2019 Mar; 38(1):40-45. PubMed ID: 30924914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery.
    Ro KW; Seo SH; Son SW; Kim IH
    Ann Dermatol; 2011 Aug; 23(3):276-81. PubMed ID: 21909195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
    Cerci FB; Kubo EM; Werner B; Tolkachjov SN
    J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
    Sohn GK; Keniston K; Kannan S; Hinds B; Jian SIB
    J Drugs Dermatol; 2021 Aug; 20(8):874-879. PubMed ID: 34397195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key characteristics of basal cell carcinoma with large subclinical extension.
    Greywal T; Goldenberg A; Eimpunth S; Jiang SB
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):485-490. PubMed ID: 31419354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of autofluorescence-Raman microspectroscopy for surgical margin assessment during Mohs micrographic surgery of basal cell carcinoma.
    Boitor RA; Varma S; Sharma A; Odedra S; Elsheikh S; Eldib K; Patel A; Koloydenko A; Gran S; De Winne K; Koljenovic S; Williams HC; Notingher I
    Br J Dermatol; 2024 Aug; 191(3):428-436. PubMed ID: 38736216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
    Calvão J; Pinho A; Brinca A; Vieira R
    An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
    Berk DR; Ball Arefiev KL; Gladstone HB
    Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma.
    Delgado Jiménez Y; Camarero-Mulas C; Sanmartín-Jiménez O; Garcés JR; Rodríguez-Prieto MÃ; Alonso-Alonso T; Miñano Medrano R; López-Estebaranz JL; de Eusebio Murillo E; Redondo P; Ciudad-Blanco C; Toll A; Artola Igarza JL; Allende Markixana I; Suarez Fernández R; Alfaro Rubio A; Alonso Pacheco ML; Vázquez-Veiga H; de la Cueva Dobao P; Ruiz-Salas V; Vilarrasa E; Barchino L; Morales-Gordillo V; Ocerin-Guerra I; Navarro Tejedor R; Hueso L; Mayor Arenal M; Seoane-Pose MJ; Cano-Martinez N; Garcia-Doval I; Descalzo MA;
    Int J Dermatol; 2018 Nov; 57(11):1375-1381. PubMed ID: 30246444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
    Fantini BC; Bueno Filho R; Chahud F; Souza CDS
    J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension.
    Hendrix JD; Parlette HL
    Arch Dermatol; 1996 Mar; 132(3):295-8. PubMed ID: 8607634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using optical coherence tomography to optimize Mohs micrographic surgery.
    Akella SS; Lee J; May JR; Puyana C; Kravets S; Dimitropolous V; Tsoukas M; Manwar R; Avanaki K
    Sci Rep; 2024 Apr; 14(1):8900. PubMed ID: 38632358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
    Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
    Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
    van Kester MS; Goeman JJ; Genders RE
    J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.